M. Quinn

发表

Fourier Transform Infrared Imaging and Unsupervised Hierarchical Clustering Applied to Cervical Biopsies

K. Bambery, B. Wood, M. Quinn, 2004 .

Fourier transform infrared (FTIR) spectral mapping of the cervical transformation zone, and dysplastic squamous epithelium.

M. Diem, B. Wood, M. Quinn, 2004, Gynecologic oncology.

An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum

G. Rice, M. Quinn, N. Ahmed, 2003, Proteomics.

Low dose cyclophosphamide: Mechanisms of T cell modulation.

M. Quinn, M. Plebanski, M. Madondo, 2016, Cancer treatment reviews.

LOW-GRADE SEROUS CARCINOMA ( LGSC ) 1

A. Kawabata, N. Yanaihara, A. Okamoto, 2018 .

A new prognostic model for FIGO stage 1 epithelial ovarian cancer.

I. Vergote, M. Quinn, A. Proietto, 2007, Gynecologic oncology.

2D-PAGE of ovarian cancer: analysis of soluble and insoluble fractions using medium-range immobilized pH gradients.

G. Rice, M. Quinn, M. Lappas, 2011, Biochemical and biophysical research communications.

A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer.

M. Quinn, M. Friedlander, D. Rischin, 2004, Gynecologic oncology.

Overexpression of αvβ6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade

G. Rice, S. Mok, M. Quinn, 2002 .

VIN 3: a clinicopathologic review

M. Quinn, O. Mcnally, N. Mulvany, 2002, International Journal of Gynecologic Cancer.

VIN 3: a clinicopathologic review

M. Quinn, N. Mulvany, R. Pagano, 2002, International Journal of Gynecologic Cancer.

Precancerous changes in the cervix and risk of subsequent preterm birth

M. Quinn, J. Lumley, F. Bruinsma, 2006 .

Postpartum Spinal Wedge Fractures in a 27‐Year‐Old Epileptic Anorectic Woman

M. Quinn, J. Evans, H. Baker, 1987, The Australian & New Zealand journal of obstetrics & gynaecology.

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

M. Parmar, E. Eisenhauer, G. Rustin, 2010, International Journal of Gynecologic Cancer.

Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.

Alexander M. Metcalf, A. Spurdle, F. Lose, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion

M. Quinn, A. Östör, A. Lopata, 2002, Cancer.

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

H. Putter, C. Haie-meder, H. Kitchener, 2018, The Lancet. Oncology.

Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy

M. Quinn, M. Plebanski, S. Xiang, 2012, Cancers.

Long‐term outcomes after progestogen treatment for early endometrial cancer

M. Quinn, T. Cade, R. Rome, 2013, The Australian & New Zealand journal of obstetrics & gynaecology.

Women with low‐grade abnormalities on Pap smear should be referred for colposcopy

M. Quinn, Jeffrey H J Tan, Amanda Fairman, 2004, The Australian & New Zealand journal of obstetrics & gynaecology.

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma

G. Rice, M. Quinn, C. Riley, 2004, British Journal of Cancer.

Role of Integrin Receptors for Fibronectin, Collagen and Laminin in the Regulation of Ovarian Carcinoma Functions in Response to a Matrix Microenvironment

G. Rice, M. Quinn, C. Riley, 2005, Clinical & Experimental Metastasis.

Hormonal treatment of endometrial cancer.

M. Quinn, 1999, Hematology/oncology clinics of North America.

Proteomic profiling of proteins associated with urokinase plasminogen activator receptor in a colon cancer cell line using an antisense approach

G. Rice, M. Quinn, N. Ahmed, 2003, Proteomics.

FETAL DEATH FOLLOWING EXTRA‐AMNIOTIC PROSTAGLANDIN GEL REPORT OF TWO CASES

M. Quinn, M. Quinn, A. Murphy, 1981, British journal of obstetrics and gynaecology.

Single Dose Extra‐Amniotic Prostaglandin Gel for Midtrimester Termination of Pregnancy

M. Quinn, R. Wein, M. Kloss, 1980, The Australian & New Zealand journal of obstetrics & gynaecology.

Impact of weight change and weight cycling on risk of different subtypes of endometrial cancer.

A. Spurdle, M. Quinn, C. Bain, 2013, European journal of cancer.

How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country

M. Quinn, J. Lew, K. Canfell, 2017, International journal of cancer.

Prognostic significance of several histological features in intermediate and high‐risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy

M. Quinn, K. Narayan, A. Herschtal, 2009, Journal of medical imaging and radiation oncology.

Sexual function after treatment of gynaecological cancer

M. Quinn, 2007 .

Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection.

J. McNeil, S. Garland, M. Quinn, 1992, The Journal of infectious diseases.

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference

N. Yanaihara, A. Okamoto, J. Ledermann, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Detection of endometrial cancer by determination of matrix metalloproteinases in the uterine cavity.

M. Quinn, Catherine C. Smith, A. Lopata, 2003, Gynecologic oncology.

Neuronal transcription factor Brn-3a(l) is over expressed in high-grade ovarian carcinomas and tumor cells from ascites of patients with advanced-stage ovarian cancer

M. Quinn, C. Riley, N. Ahmed, 2010, Journal of ovarian research.

Oral cyclophosphamide in recurrent ovarian cancer

M. Quinn, L. Mileshkin, D. Rischin, 2016, Asia-Pacific journal of clinical oncology.

Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer)

E. Eisenhauer, G. Rustin, I. Vergote, 2005 .

Mutation analysis of CDP, TP53, and KRAS in uterine leiomyomas

G. Rice, M. Quinn, M. Baker, 2003, Molecular carcinogenesis.

Abnormal Cervical Cytology in Pregnancy: Experience of 811 Cases

M. Quinn, M. Quinn, M. Permezel, 1998, The Australian & New Zealand journal of obstetrics & gynaecology.

Adenocarcinoma of the cervix.

M. Quinn, 1998, Annals of the Academy of Medicine, Singapore.

Clearance of Human Papillomavirus in Women Treated for Cervical Dysplasia

S. Garland, M. Quinn, S. Tabrizi, 2011, Obstetrics and gynecology.

Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors.

M. Quinn, L. Ward, M. Janda, 2017, Gynecologic oncology.

Title : Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer – a population-based study

A. deFazio, M. Quinn, C. Steer, 2013 .

Clear‐cell cancer of the ovary—is it chemosensitive?

M. Quinn, S. Pather, 2005, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Clear-cell cancer of the ovary—is it chemosensitive?

M. Quinn, S. Pather, 2004, International Journal of Gynecologic Cancer.

CHAPTER 11 How to manage and communicate with patients about HPV?

S. Garland, M. Quinn, 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

When Should Surgery Be Performed for the First-Line Treatment of Advanced Ovarian Cancer?

J. Ledermann, M. Quinn, G. Mohan, 2014 .

A Randomized, Double-Blinded, Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor (rhuLIF, Emfilermin, AM424) to Prevent Chemotherapy-Induced Peripheral Neuropathy

J. Arezzo, M. Quinn, L. Kiers, 2005, Clinical Cancer Research.

A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The OUTBACK TRIAL.

M. Stockler, V. Gebski, E. Trimble, 2012 .

Microinvasive Adenocarcinoma of the Cervix: A Clinicopathologic Study of 77 Women

M. Quinn, A. Östör, R. Rome, 1997, Obstetrics and gynecology.

Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas.

G. Rice, M. Quinn, E. Moses, 2000, Gynecologic oncology.

Differential expression of the α2-macroglobulin receptor and the receptor associated protein in normal human endometrium and endometrial carcinoma

G. Rice, M. Quinn, E. Moses, 2000 .

Identification and partial characterization of differentially expressed mRNAs in normal human endometria and endometrial carcinomas by differential display RT-PCR.

G. Rice, M. Quinn, E. Moses, 2000, Molecular human reproduction.

Factors Influencing Serum CA 125 Levels in Normal Women

M. Quinn, S. Grover, P. Weideman, 1992, Obstetrics and gynecology.

First-Line Therapy in Ovarian Cancer Trials

H. Kitchener, J. McAlpine, L. Rubinstein, 2011, International Journal of Gynecologic Cancer.

Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations

Brit B. Turnbull, H. Kohrt, B. Narasimhan, 2014, Journal of Translational Medicine.

Guidelines following hydatidiform mole: A reappraisal

M. Quinn, R. Bekkers, J. Pyman, 2006, The Australian & New Zealand journal of obstetrics & gynaecology.

Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment.

M. Quinn, M. Plebanski, M. Madondo, 2013, Clinical immunology.

Hormone replacement therapy and risk of epithelial ovarian cancer

N. Hacker, M. Quinn, V. Siskind, 1999, British Journal of Cancer.

Multidisciplinary care for women with early breast cancer in the Australian context

M. Quinn, 2004, The Medical journal of Australia.

Association between αvβ6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen‐dependent matrix degradation in ovarian cancer

G. Rice, M. Quinn, M. Baker, 2002 .

The effect of the menstrual cycle on serum CA 125 levels: a population study.

M. Quinn, S. Grover, P. Weideman, 1992, American journal of obstetrics and gynecology.

Precancerous changes in the cervix and risk of subsequent preterm birth

M. Quinn, J. Lumley, F. Bruinsma, 2006, BJOG : an international journal of obstetrics and gynaecology.

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

E. Eisenhauer, G. Rustin, I. Vergote, 2005, Journal of the National Cancer Institute.

Is colposcopy needed following laser ablation for dysplasia?

M. Quinn, D. Neesham, Jeffrey H J Tan, 2006, The Australian & New Zealand journal of obstetrics & gynaecology.

Steroid receptors and ovarian tumors: variation within primary tumors and between primary tumors and metastases.

M. Quinn, D. Fortune, R. Rome, 1988, Gynecologic oncology.

Intraperitoneal distribution imaging in ovarian cancer patients

S. Dawson, M. Quinn, R. Hicks, 2011, Internal medicine journal.

Integration of new or experimental treatment options and new approaches to clinical trials.

E. Trimble, M. Quinn, S. Grénman, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.

M. Quinn, R. Bekkers, R. Rome, 2007, Gynecologic oncology.

History, scope and methodology of the 3rd International Consensus Workshop on Ovarian Cancer 2004.

M. Parmar, J. Neijt, M. Quinn, 2005, Annals of Oncology.

High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-up

M. Quinn, U. Puistola, R. Henrique, 1997 .

Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases

M. Quinn, D. Neesham, C. Black, 2015, International Journal of Gynecologic Cancer.

A prospective study of inhibin in granulosa cell tumors of the ovary.

H. Burger, M. Quinn, P. Mamers, 1994, Gynecologic oncology.

Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors.

H. Burger, M. Quinn, J. Campbell, 1994, The New England journal of medicine.

Tamoxifen and Aminoglutethimide in the Management of Patients With Advanced Endometrial Carcinoma Not Responsive to Medroxyprogesterone

M. Quinn, J. Campbell, R. Pepperell, 1981, The Australian & New Zealand journal of obstetrics & gynaecology.

Plasminogen fragmentation and increased production of extracellular matrix-degrading proteinases are associated with serous epithelial ovarian cancer progression.

G. Rice, M. Quinn, M. Baker, 2004, Gynecologic oncology.

Lack of association between HLA DQB1 alleles with HPV infection and histology findings in cervical cancer in Australian women.

S. Garland, M. Quinn, S. Tabrizi, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma

G. Rice, M. Quinn, C. Riley, 2005, British Journal of Cancer.

Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden

M. Quinn, N. Ahmed, E. Thompson, 2014, Front. Oncol..

Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.

G. Rice, M. Quinn, M. Baker, 2002, Journal of cellular biochemistry.

Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.

G. Rice, S. Mok, M. Quinn, 2002, Carcinogenesis.

Developing an international network for clinical research: the Gynecological Cancer Intergroup experience

M. Quinn, 2012 .

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours.

E. Kohn, A. Okamoto, D. Provencher, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Reply to J. Moline et al.

Alexander M. Metcalf, A. Spurdle, F. Lose, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The Absence of Genital Human Papillomavirus DNA in Virginal Women

S. Garland, M. Quinn, S. Tabrizi, 1992, International journal of STD & AIDS.

Does experience in colposcopy improve identification of high grade abnormalities?

J. Hendriks, M. Quinn, R. Bekkers, 2008, European journal of obstetrics, gynecology, and reproductive biology.

Prognostic significance of steroid receptor positivity and adjuvant progestogen use in endometrial stromal sarcoma

M. Quinn, A. Polyakov, R. Rome, 2014, The Australian & New Zealand journal of obstetrics & gynaecology.

Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)

Jae-Weon Kim, D. Provencher, J. Ledermann, 2014, International Journal of Gynecologic Cancer.

Fetal Intravascular Transfusion for Severe Erythroblastosis: Effects on Haematology and Survival

L. Doyle, M. Quinn, J. Barrie, 1986, The Australian & New Zealand journal of obstetrics & gynaecology.

Gynecologic Cancer: Controversies in Management

M. Gore, M. Quinn, D. Gershenson, 2004 .

Mode Of Delivery Of Preterm Twins

L. Doyle, M. Quinn, W. Kitchen, 1988, The Australian & New Zealand journal of obstetrics & gynaecology.

Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium.

S. Dedhar, M. Quinn, N. Auersperg, 2006, American journal of physiology. Cell physiology.

Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer

M. Quinn, M. Plebanski, O. Mcnally, 2020, Scientific Reports.

An Investigation into FTIR Spectroscopy as a Biodiagnostic Tool for Cervical Cancer

Frank R. Burden, Bayden R. Wood, Donald McNaughton, 1998 .

FTIR microspectroscopic study of cell types and potential confounding variables in screening for cervical malignancies.

B. Wood, M. Quinn, D. McNaughton, 1998, Biospectroscopy.

Southern blot and dot blot hybridisation compared to PCR for the detection of human papillomavirus DNA in biopsies of the uterine cervix from women with dysplasia.

S. Garland, M. Quinn, S. Tabrizi, 1993, Clinical and diagnostic virology.

Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer

Nuzhat Ahmed, M. Quinn, N. Ahmed, 2005, Proteomics.

Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary

M. Quinn, N. Ahmed, J. Findlay, 2012, Journal of Ovarian Research.

Elevated Serum Inhibin Concentrations in Postmenopausal Women with Ovarian Tumors

H. Burger, M. Quinn, J. Campbell, 1993 .

Response of a mucinous ovarian tumor of borderline malignancy to human chorionic gonadotropin.

M. Quinn, D. Fortune, J. Brown, 1983, Obstetrics and gynecology.

Identification of patients with persistent trophoblastic disease after complete hydatidiform mole by using a normal 24-hour urine hCG regression curve.

M. Quinn, R. Bekkers, O. Mcnally, 2014, Gynecologic oncology.

Persistent trophoblast disease following partial molar pregnancy

M. Quinn, R. Bekkers, J. Pyman, 2006, The Australian & New Zealand journal of obstetrics & gynaecology.

EMACO in High Risk Gestational Trophoblast Disease ‐ The Australian Experience

M. Friedlander, M. Quinn, I. Hammond, 1994, The Australian & New Zealand journal of obstetrics & gynaecology.

Successful treatment of mother and baby with metastatic choriocarcinoma.

M. Quinn, D. Fortune, O. McNally, 2002, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Collision Tumor: Serous Adenocarcinoma and Steroid Cell Tumor of the Ovary

M. Quinn, A. Östör, A. Nirenberg, 1992, Pathology.

First reported case of endometrial carcinoma in association with HIV infection.

M. Quinn, J. Torresi, G. Gard, 1999, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

A Randomized , Double-Blinded , Placebo-Controlled Phase II Trial of Recombinant Human Leukemia Inhibitory Factor ( rhuLIF , Emfilermin , AM 424 ) to Prevent Chemotherapy-Induced Peripheral Neuropathy

J. Arezzo, M. Quinn, L. Kiers, 2005 .

A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer

M. Quinn, N. Ahmed, R. Luwor, 2015, Molecular Cancer.

A critical role of Oct 4 A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer

M. Quinn, N. Ahmed, R. Luwor, 2015 .

Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells

M. Quinn, M. Plebanski, M. Madondo, 2017, Front. Immunol..

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell‐like profile

M. Quinn, N. Ahmed, Clifford Liongue, 2011, Journal of cellular biochemistry.

Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.

M. Quinn, N. Ahmed, J. Findlay, 2010, Current cancer drug targets.

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer

M. Quinn, M. Plebanski, O. Mcnally, 2015, BioMed research international.

The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.

A. Spurdle, M. Quinn, M. Oehler, 2018, Gynecologic oncology.

Distinct molecular signature of recurrent ovarian tumor cells isolated from the ascites of advanced-stage serous ovarian cancer patients

M. Quinn, N. Ahmed, E. Thompson, 2014 .

Serum HE4 as a prognostic marker in endometrial cancer--a population based study.

Alexander M. Metcalf, A. Spurdle, M. Quinn, 2014, Gynecologic oncology.

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors

M. Quinn, Hong-Jian Zhu, N. Ahmed, 2012, PloS one.

A phase 2, single-arm study of an autologous dendritic cell treatment against mucin 1 in patients with advanced epithelial ovarian cancer

M. Quinn, G. Pietersz, B. Loveland, 2014, Journal of Immunotherapy for Cancer.

Functioning Ovarian Tumors in Postmenopausal Women

M. Quinn, D. Fortune, J. Brown, 1981, Obstetrics and gynecology.

The impact of PET/CT in the management of recurrent ovarian cancer.

M. Quinn, R. Hicks, D. Neesham, 2006, Gynecologic oncology.

Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies.

M. Quinn, J. Campbell, I. Bertoncello, 1982, British Journal of Cancer.

Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer.

Monika Janda, Andreas Obermair, Peter O'Rourke, 2015, Gynecologic oncology.

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial

Jacobus Pfisterer, Gordon C Jayson, Michael Quinn, 2015, The Lancet. Oncology.

2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

E. Trimble, M. Parmar, E. Eisenhauer, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

A case of early-stage epithelial ovarian cancer in pregnancy.

M. Quinn, G. Otton, K. Phillips, 2001, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

SCLEROSING STROMAL TUMOUR OF THE OVARY CASE REPORT WITH ENDOCRINE STUDIES

M. Quinn, D. Fortune, B. Hudson, 1981, British journal of obstetrics and gynaecology.

Malignant Transformation Within Ovarian Dermoid Cysts: an Audit of Treatment Received and Patient Outcomes. an Australia New Zealand Gynaecological Oncology Group (ANZGOG) and Gynaecologic Cancer Intergroup (GCIG) Study

A. Tinker, M. lenhard, M. Friedlander, 2009, International Journal of Gynecologic Cancer.

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference

A. Kawabata, N. Yanaihara, A. Okamoto, 2017, Journal of gynecologic oncology.

Cell-Free 59 kDa Immunoreactive Integrin-Linked Kinase

G. Rice, M. Quinn, N. Ahmed, 2004, Clinical Cancer Research.

Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells

M. Quinn, M. Baker, I. Campbell, 2006, Molecular carcinogenesis.

Endometrial carcinoma in premenopausal women: a clinicopathological study.

M. Quinn, D. Fortune, B. Kneale, 1985, Gynecologic oncology.

Improving response to progestin treatment of low-grade endometrial cancer

D. Huntsman, J. McAlpine, M. Quinn, 2020, International Journal of Gynecological Cancer.

Cancerous ovarian stem cells: Obscure targets for therapy but relevant to chemoresistance

M. Quinn, N. Ahmed, J. Findlay, 2013, Journal of cellular biochemistry.

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden

M. Quinn, Hong-Jian Zhu, N. Ahmed, 2013, Molecular Cancer.

Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer

M. Quinn, V. Siskind, C. Bain, 1997, International journal of cancer.

HPV genotype prevalence in women with abnormal pap smears in Melbourne, Australia

S. Garland, M. Quinn, S. Tabrizi, 2009, Journal of medical virology.

Should all women be vaccinated against human papillomavirus and what effect will this have on screening programs

M. Quinn, 2007 .

The Prevalence, Incidence, and Quality-of-Life Impact of Lymphedema After Treatment for Vulvar or Vaginal Cancer

M. Quinn, L. Ward, M. Janda, 2018 .

Screening for ovarian cancer

M. Quinn, C. Anderiesz, 2001, The Medical journal of Australia.

Transabdominal cervical cerclage

M. Quinn, M. Umstad, A. Ades, 2010, The Australian & New Zealand journal of obstetrics & gynaecology.

Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results

S. Garland, M. Quinn, S. Tabrizi, 2007, Journal of Clinical Microbiology.

αvβ6 Integrin-A Marker for the Malignant Potential of Epithelial Ovarian Cancer

G. Rice, M. Quinn, M. Baker, 2002 .

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer

M. Quinn, N. Ahmed, R. Luwor, 2016, BMC Cancer.

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

M. Quinn, N. Ahmed, E. Thompson, 2014, BMC Cancer.

Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR–β1 integrin complex in colon cancer cells

G Rice, G. Rice, M. Quinn, 2003, British Journal of Cancer.

Survival of Australian women with invasive epithelial ovarian cancer: a population‐based study

M. Friedlander, M. Quinn, C. Steer, 2014, The Medical journal of Australia.

CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?

M. Quinn, B. Coventry, S. Markovic, 2009, Journal of Translational Medicine.

Epithelial–mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: An exception to the norm

M. Quinn, N. Ahmed, E. Thompson, 2007, Journal of cellular physiology.

Hormonal therapies and gynaecological cancers.

M. Quinn, A. Garrett, 2008, Best practice & research. Clinical obstetrics & gynaecology.

Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.

A. deFazio, M. Quinn, C. Steer, 2013, Gynecologic Oncology.

Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.

M. Birrer, D. Mutch, M. Quinn, 2017, Gynecologic oncology.

Ovarian cancer: patterns of care in Victoria during 1993–1995

G. Giles, P. Francis, M. Quinn, 2002, The Medical journal of Australia.

Adjuvant chemotherapy and chemoradiation following surgery for high-risk endometrial cancer.

M. Quinn, L. Mileshkin, D. Rischin, 2010 .

Predictors of depression and anxiety symptom trajectories in the 24 months following diagnosis of breast or gynaecologic cancer.

M. Quinn, C. Bousman, L. Stafford, 2016, Breast.

Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome

M. Quinn, L. Stafford, G. Mann, 2015, Supportive Care in Cancer.

PARAGON: Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynecologic neoplasms: ANZGOG 0903.

M. Stockler, V. Gebski, P. Beale, 2013 .

An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours

M. Quinn, C. Riley, N. Ahmed, 2008, British Journal of Cancer.

Improving treatment for obese women with early stage cancer of the uterus: rationale and design of the levonorgestrel intrauterine device ± metformin ± weight loss in endometrial cancer (feMME) trial.

V. Gebski, M. Quinn, M. Janda, 2014, Contemporary clinical trials.

Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer

K. Byth, S. Fox, S. Lade, 2014, Scientific Reports.

Collaborations in gynecologic oncology education and research in low- and middle- income countries: Current status, barriers and opportunities

T. Rebbeck, E. Trimble, J. Berek, 2018, Gynecologic oncology reports.

Variations in adjuvant chemotherapy and survival in women with epithelial ovarian cancer – a population-based study

M. Quinn, C. Steer, M. Friedlander, 2016, Acta oncologica.

Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

M. Quinn, Hong-Jian Zhu, N. Ahmed, 2014, BMC Cancer.

α2β1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis

G. Rice, M. Quinn, C. Riley, 2007, Journal of Carcinogenesis.

Endometrial cancer risk and survival by tumor MMR status

A. Spurdle, M. Quinn, D. Buchanan, 2018, Journal of gynecologic oncology.

Genistein-induced proteome changes in the human endometrial carcinoma cell line, ishikawa

G. Rice, M. Quinn, M. Larsen, 2006, Clinical Proteomics.

Proteomic Profiling of Ovarian Cancer Plasma using Immunoaffinity Depleted Plasma and Two-Dimensional PAGE

G. Rice, M. Quinn, K. Oliva, 2007, Clinical Proteomics.

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia.

I. Frazer, M. Quinn, S. Edwards, 2004, Vaccine.

Neutrophil gelatinase‐associated lipocalin (NGAL) an early‐screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor‐induced epithelio‐mesenchymal transition

G. Rice, M. Quinn, R. Lim, 2007, International journal of cancer.

The contribution of spirituality and spiritual coping to anxiety and depression in women with a recent diagnosis of gynecological cancer

M. Quinn, D. Clarke, T. Jobling, 2004, International Journal of Gynecologic Cancer.

Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses

M. Quinn, M. Plebanski, M. Madondo, 2023, Cancers.

Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities.

M. Quinn, M. Plebanski, A. Stephens, 2017, Current medicinal chemistry.

Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer

M. Quinn, M. Plebanski, M. Madondo, 2020, Scientific Reports.

Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer

G. Rice, M. Quinn, B. Kemp, 2004, British Journal of Cancer.

Phase II trial of VP-16-213 in advanced ovarian carcinoma.

M. Quinn, J. Campbell, R. Pepperell, 1985, Gynecologic oncology.

3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.

E. Trimble, M. Parmar, E. Eisenhauer, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer.

M. Quinn, V. Beesley, M. Janda, 2014, Gynecologic oncology.

Screening for cervical cancer — where are we going wrong?

M. Quinn, M A Quinn, 1989, The Medical journal of Australia.

Cervical cancer — what role for human papillomavirus?

S. Garland, M. Quinn, D. Fortune, 1992, The Medical journal of Australia.

Outcomes after cervical cold knife conization with complete and incomplete excision of abnormal epithelium: a review of 699 cases.

M. Quinn, J. Tan, K. Mohamed-Noor, 1997, Gynecologic oncology.

“Spurious” Labour — Does it Matter?

M. Quinn, A. Murphy, Jane Gallagher, 1981, The Australian & New Zealand journal of obstetrics & gynaecology.

A Study of Women Who Appear to Default from Management of an Abnormal Pap Smear

M. Quinn, J. Hoy, Heather Mitchell Md, 1992, The Australian & New Zealand journal of obstetrics & gynaecology.

Prognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: a multinational collaborative study (ANZGOG0801).

M. Quinn, H. Ngan, P. Zusterzeel, 2012, Gynecologic oncology.

Nomogram to Predict the Probability of Relapse in Patients Diagnosed With Borderline Ovarian Tumors

M. Quinn, H. Ngan, P. Zusterzeel, 2012, International Journal of Gynecologic Cancer.

FIGO Cancer Report 2015

M. Quinn, L. Denny, 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Women with a Pelvic Mass ‐ When to Perform an Ultrasound

M. Quinn, R. Rome, J. Dowd, 1993, The Australian & New Zealand journal of obstetrics & gynaecology.

Chapter 8: Screening for cervical cancer in developing countries.

Michael Quinn, Lynette Denny, M. Quinn, 2006, Vaccine.

Detection of genital human papillomavirus (HPV) DNA by PCR and other conventional hybridisation techniques in male partners of women with abnormal Papanicolaou smears.

S. Garland, M. Quinn, S. Tabrizi, 1992, Genitourinary medicine.

Influence of quartile of menstrual cycle on pellet volume of specimens from tampons and isolation of human papillomavirus.

M. Quinn, S. Tabrizi, C. Fairley, 1992, The Journal of infectious diseases.

Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.

M. Quinn, D. Fortune, M. Cauchi, 1985, Gynecologic oncology.

Findings and Outcomes in a Prevaccination Cohort of Women Younger Than 25 Years Attending a Tertiary Colposcopy Service

M. Quinn, C. Wrede, Y. Jayasinghe, 2016, Journal of lower genital tract disease.

Management of Uterine Leiomyosarcoma in Australia

M. Quinn, N. Mulvany, Gregory B. Card, 1999, The Australian & New Zealand journal of obstetrics & gynaecology.

Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer.

G. Rice, M. Quinn, M. Baker, 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months

M. Quinn, L. Stafford, G. Mann, 2013, Psycho-oncology.

Patterns of inheritance of ovarian cancer. An analysis from an ovarian cancer screening program

M. Quinn, S. Grover, P. Weideman, 1993, Cancer.

Removal of blood components from cervical smears: implications for cancer diagnosis using FTIR spectroscopy.

Melissa J Romeo, Don McNaughton, Bayden R Wood, 2003, Biopolymers.

Clinical trials in gynecological cancer

E. Trimble, J. Ledermann, P. Disaia, 2006, International Journal of Gynecologic Cancer.

Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.

A. Spurdle, J. Kirk, M. Quinn, 2017, Gynecologic oncology.

A randomized clinical trial of beta carotene vs placebo for the treatment of cervical HPV infection

J. McNeil, S. Garland, M. Quinn, 1996 .

Influence of benign cellular changes in diagnosis of cervical cancer using IR microspectroscopy.

Melissa J Romeo, Frank R Burden, Don McNaughton, 2002, Biopolymers.

Effect of Silencing Neutrophil Gelatinase-Associated Lipocalin in Ovarian Cancer Cells on Epithelio-Mesenchymal Transition

G. Rice, M. Quinn, M. Lappas, 2011 .

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden

M. Quinn, N. Ahmed, E. Thompson, 2013, Molecular Cancer.

Prognostic Factors for Recurrence in Patients With FIGO Stage I and II Intermediate or High Risk Endometrial Cancer

M. Quinn, J. Hendriks, R. Bekkers, 2008 .

Tamoxifen therapy in advanced/recurrent endometrial carcinoma.

M. Quinn, J. Campbell, 1989, Gynecologic oncology.

Use of Vaginal Prostaglandin Gel before Induction of Labour

M. Quinn, A. Murphy, M. Jalland, 1980, The Australian & New Zealand journal of obstetrics & gynaecology.

Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.

E. Domingo, M. Quinn, Michael A Quinn, 2008, Vaccine.

Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.

G. Rice, M. Quinn, E. Thompson, 2004, Gynecologic oncology.

What Is the Value of Lymphadenectomy in Early Ovarian Cancer

M. Quinn, S. Mahner, J. Pfisterer, 2014 .

Screening and prevention of gynaecological cancer

M. Quinn, 2003 .

Infrared imaging of normal and diseased cervical tissue sections

Max Diem, Michael Quinn, Don McNaughton, 2005, SPIE Micro + Nano Materials, Devices, and Applications.

An alternative cost effectiveness analysis of ThinPrep in the Australian setting

M. Quinn, A. Neville, 2005, The Australian & New Zealand journal of obstetrics & gynaecology.

Clinical trials in gynecological cancer.

E. Trimble, J. Ledermann, P. Disaia, 2007, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Uterine sarcoma: steroid receptors and response to hormonal therapy.

M. Quinn, I. Hammond, M. Cauchi, 1990, Gynecologic oncology.

Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference.

N. Yanaihara, A. Okamoto, M. Quinn, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia

S. Garland, M. Quinn, S. Tabrizi, 2005, International Journal of Gynecologic Cancer.

Evaluation of p16INK4a immunostaining for the detection of high-grade changes in cervical cytology

S. Garland, M. Quinn, S. Tabrizi, 2015, Pathology.

FIGO Cancer Report 2012

N. Hacker, M. Quinn, L. Denny, 2012, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Expression and localization of αvβ6 integrin in extraplacental fetal membranes: possible role in human parturition

G. Rice, M. Quinn, C. Riley, 2004 .

Comparison of the hospital anxiety and depression scale and the center for epidemiological studies depression scale for detecting depression in women with breast or gynecologic cancer.

M. Quinn, L. Stafford, G. Mann, 2014, General hospital psychiatry.

Screening for ovarian cancer.

M. Quinn, 2001, Australian Family Physician.

Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum.

N. Hacker, J. Berek, M. Quinn, 2015, European journal of gynaecological oncology.

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples

S. Garland, M. Quinn, S. Tabrizi, 2017, Papillomavirus research.

Anyplex II HPV28 detection and Anyplex II HPV HR detection assays are highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

S. Garland, M. Quinn, S. Tabrizi, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

EUROarray human papillomavirus (HPV) assay is highly concordant with other commercial assays for detection of high-risk HPV genotypes in women with high grade cervical abnormalities

S. Garland, M. Quinn, S. Tabrizi, 2016, European Journal of Clinical Microbiology and Infectious Diseases.

Comparison of the Roche Cobas(®) 4800 HPV assay to Digene Hybrid Capture 2, Roche Linear Array and Roche Amplicor for Detection of High-Risk Human Papillomavirus Genotypes in Women undergoing treatment for cervical dysplasia.

S. Garland, M. Quinn, S. Tabrizi, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Antihypertensive treatment in pregnancy

L. Doyle, M. Quinn, 1985, British medical journal.

Endometrial cancer.

M. Quinn, V. Arora, 2012, Best Practice & Research: Clinical Obstetrics & Gynaecology.

Clinical Utility of Real-Time Targeted Molecular Profiling in the Clinical Management of Ovarian Cancer: The ALLOCATE Study.

N. Traficante, D. Bowtell, M. Christie, 2019, JCO precision oncology.

Adenocarcinoma of the cervix--are there arguments for a different treatment policy?

M. Quinn, 1997, Current opinion in obstetrics & gynecology.

A Phase II Trial of Carboplatin and Etoposide for Relapsed or Metastatic Carcinoma of the Cervix

M. Quinn, M. Millward, D. Rischin, 1998, The Australian & New Zealand journal of obstetrics & gynaecology.

A three-dimensional multivariate image processing technique for the analysis of FTIR spectroscopic images of multiple tissue sections

Bayden R. Wood, Donald McNaughton, Keith R. Bambery, 2006, BMC Medical Imaging.

“I want the one for older women” — extending the human papillomavirus vaccine population base

M. Quinn, Jeffrey H J Tan, 2008, The Medical journal of Australia.

Characteristics of ovarian and uterine cancers in a cohort of in vitro fertilization patients.

A. Venn, M. Quinn, M. Quinn, 2001, Gynecologic oncology.

Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer

M. Quinn, J. Hendriks, R. Bekkers, 2008, Acta obstetricia et gynecologica Scandinavica.

Small cell of the ovary, hypercalcemic type -- analysis of combined experience and recommendation for management. A GCIG study.

J. Ledermann, G. Rustin, M. Friedlander, 2006, Gynecologic oncology.

Predictive Value of Magnetic Resonance Imaging in Assessing Myometrial Invasion in Endometrial Cancer: Is Radiological Staging Sufficient for Planning Conservative Treatment?

M. Quinn, J. Pyman, A. Dobrotwir, 2010, International Journal of Gynecologic Cancer.

Outcome in women with no endocervical component on cervical cytology after treatment for high‐grade cervical dysplasia

M. Quinn, Jeffrey H J Tan, Alice Huang, 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

Benign endocervical cystic glandular change mimicking minimal deviation adenocarcinoma of the cervix on magnetic resonance imaging: A case report

M. Quinn, A. Dobrotwir, D. Neesham, 2004, Australian and New Zealand journal of obstetrics and gynaecology.

Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.

A. deFazio, M. Quinn, C. Steer, 2013, Gynecologic Oncology.

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell‐like profile

M. Quinn, N. Ahmed, Clifford Liongue, 2011, Journal of cellular biochemistry.

Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases

M. Quinn, D. Neesham, C. Black, 2015, International Journal of Gynecologic Cancer.

Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer).

E. Eisenhauer, G. Rustin, I. Vergote, 2005, Journal of the National Cancer Institute.

Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.

A. Spurdle, J. Kirk, M. Quinn, 2017, Gynecologic oncology.

Cervical screening in the 21st century.

M. Quinn, 2004, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: Outback (ANZGOG0902/GOG0274/RTOG1174).

M. Stockler, V. Gebski, M. King, 2014 .

Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer.

A. Spurdle, M. Quinn, V. Beesley, 2015, Gynecologic oncology.